5451 - 5475 of 5832 Results
Title
Year
-
OPENTitle: A Link between Autophagy and the Pathophysiology of LRRK2 in Parkinson's DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2012Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/324521Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/324521.pdfCitation Count: 26
- A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s Disease2012OPENTitle: A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/364684Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/364684.pdfCitation Count: 17
- Cognitive Profiles in Parkinson’s Disease and Their Relation to Dementia: A Data-Driven Approach2012OPENTitle: Cognitive Profiles in Parkinson’s Disease and Their Relation to Dementia: A Data-Driven ApproachJournal Name: International Journal of Alzheimer's DiseasePublisher: Hindawi LimitedVol: 2012Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/910757Best OA location URL: https://downloads.hindawi.com/journals/ijad/2012/910757.pdfCitation Count: 12
-
OPENTitle: Declining Quality of Life in Parkinson Disease Before and After DiagnosisJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 2Issue #: 2Start Page: 153End Page: 160Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-2012-12083Best OA location URL: https://europepmc.org/articles/pmc3744127?pdf=renderCitation Count: 9
-
OPENTitle: Imaging of microglia in patients with neurodegenerative disordersJournal Name: Frontiers in PharmacologyPublisher: Frontiers Media SAVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fphar.2012.00096Best OA location URL: https://www.frontiersin.org/articles/10.3389/fphar.2012.00096/pdfCitation Count: 110
-
OPENTitle: Importance of the Brain Angiotensin System in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 14Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/860923Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/860923.pdfCitation Count: 28
-
OPENTitle: Interocular Asymmetry of Foveal Thickness in Parkinson DiseaseJournal Name: Journal of OphthalmologyPublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/728457Best OA location URL: https://downloads.hindawi.com/journals/joph/2012/728457.pdfCitation Count: 70
- Is Freezing of Gait in Parkinson's Disease a Result of Multiple Gait Impairments? Implications for Treatment2012OPENTitle: Is Freezing of Gait in Parkinson's Disease a Result of Multiple Gait Impairments? Implications for TreatmentJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/459321Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/459321.pdfCitation Count: 102
-
OPENTitle: Modulation of Neuronal Survival Factor MEF2 by Kinases in Parkinson’s DiseaseJournal Name: Frontiers in PhysiologyPublisher: Frontiers Media SAVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fphys.2012.00171Best OA location URL: https://www.frontiersin.org/articles/10.3389/fphys.2012.00171/pdfCitation Count: 23
-
OPENTitle: Postmortem Interval Influencesα-Synuclein Expression in Parkinson Disease BrainJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/614212Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/614212.pdfCitation Count: 12
- Practical management of heterogeneous neuroimaging metadata by global neuroimaging data repositories2012OPENTitle: Practical management of heterogeneous neuroimaging metadata by global neuroimaging data repositoriesJournal Name: Frontiers in NeuroinformaticsPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fninf.2012.00008Best OA location URL: https://www.frontiersin.org/articles/10.3389/fninf.2012.00008/pdfCitation Count: 12
- Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging2012OPENTitle: Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid ImagingJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 2Issue #: 1Start Page: 57End Page: 65Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-2012-11073Best OA location URL: https://europepmc.org/articles/pmc3423968?pdf=renderCitation Count: 39
-
OPENTitle: SIRT2 as a Therapeutic Target for Age-Related DisordersJournal Name: Frontiers in PharmacologyPublisher: Frontiers Media SAVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fphar.2012.00082Best OA location URL: https://www.frontiersin.org/articles/10.3389/fphar.2012.00082/pdfCitation Count: 124
- The Anticholinesterase Phenserine and Its Enantiomer Posiphen as 5′Untranslated-Region-Directed Translation Blockers of the Parkinson’s Alpha Synuclein Expression2012OPENTitle: The Anticholinesterase Phenserine and Its Enantiomer Posiphen as 5′Untranslated-Region-Directed Translation Blockers of the Parkinson’s Alpha Synuclein ExpressionJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 13Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/142372Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/142372.pdfCitation Count: 44
- The Unified Parkinson�s Disease Rating Scale as a predictor of peak aerobic capacity and ambulatory function2012OPENTitle: The Unified Parkinson�s Disease Rating Scale as a predictor of peak aerobic capacity and ambulatory functionJournal Name: The Journal of Rehabilitation Research and DevelopmentPublisher: Journal of Rehabilitation Research & DevelopmentVol: 49Issue #: 8Start Page: 1269End Page: 1269Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1682/jrrd.2011.06.0103Best OA location URL: https://europepmc.org/articles/pmc4545638?pdf=renderCitation Count: 22
-
OPENTitle: Web-Based Assessment of Visual and Visuospatial Symptoms in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/564812Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/564812.pdfCitation Count: 3
-
OPENTitle: Regulation of Physiologic Actions of LRRK2: Focus on AutophagyJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 10Issue #: 1-4Start Page: 238End Page: 241Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000332599Best OA location URL: https://www.karger.com/Article/Pdf/332599Citation Count: 39
-
OPENTitle: Pathophysiology of manganese-associated neurotoxicityJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 33Issue #: 4Start Page: 881End Page: 886Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2011.12.010Best OA location URL: https://europepmc.org/articles/pmc3350837?pdf=renderCitation Count: 128
- PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity2011OPENTitle: PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrityJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 21Issue #: 8Start Page: 1725End Page: 1743Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddr606Best OA location URL: https://academic.oup.com/hmg/article-pdf/21/8/1725/17258592/ddr606.pdfCitation Count: 149
- A novel neuroprotective therapy for Parkinson’s disease using a viral noncoding RNA that protects mitochondrial Complex I activity2011OPENTitle: A novel neuroprotective therapy for Parkinson’s disease using a viral noncoding RNA that protects mitochondrial Complex I activityJournal Name: Journal of Experimental MedicinePublisher: Rockefeller University PressVol: 209Issue #: 1Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1084/jem.20111126Best OA location URL: http://jem.rupress.org/content/jem/209/1/1.full.pdfCitation Count: 37
-
OPENTitle: Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriersJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 1Start Page: 55End Page: 61Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31823ed101Best OA location URL: https://europepmc.org/articles/pmc3466497?pdf=renderCitation Count: 39
-
OPENTitle: Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's diseaseJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 230Issue #: 2Start Page: 309End Page: 316Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2011.12.007Best OA location URL: https://europepmc.org/articles/pmc3324279?pdf=renderCitation Count: 143
- Feasibility, Safety, and Compliance in a Randomized Controlled Trial of Physical Therapy for Parkinson's Disease2011OPENTitle: Feasibility, Safety, and Compliance in a Randomized Controlled Trial of Physical Therapy for Parkinson's DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/795294Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/795294.pdfCitation Count: 31
- Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease2011OPENTitle: Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 71Issue #: 4Start Page: 560End Page: 568Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.22691Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/91165/1/22691_ftp.pdfCitation Count: 224
- Involvement of Perineuronal and Perisynaptic Extracellular Matrix in Alzheimer's Disease Neuropathology2011OPENTitle: Involvement of Perineuronal and Perisynaptic Extracellular Matrix in Alzheimer's Disease NeuropathologyJournal Name: Brain PathologyPublisher: WileyVol: 22Issue #: 4Start Page: 547End Page: 561Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1750-3639.2011.00557.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639011Citation Count: 141